Skip to main content
. 2017 Nov 20;8(62):106089–106097. doi: 10.18632/oncotarget.22528

Table 4. Multivariate Cox proportional hazards regression analysis.

Characteristic Hazard ratio 95% CI P-value
Age (≥60 vs. < 60 years) 1.696 0.927-3.104 0.087
T stage(T3-4 vs. T1-2) 2.768 1.603-4.779 < 0.001
N stage (N2–3 vs. N0–1) 2.165 1.245-3.765 0.006
Clinical stage (III–IVB) vs. (I–II) 9.534 1.998-45.498 0.005
PLT (>266 vs. ≤266) (×109/L) 2.017 1.329-3.060 0.001
MPV (>10.6vs.≤10.6) fL 0.645 0.404-1.028 0.065
PDW (>16.3 vs. ≤16.3) fL 2.362 1.554-3.590 < 0.001
PLR (>130.22 vs. ≤130.22) 1.523 0.933-2.487 0.092
EBV DNA (high vs. low) (copies/mL) 1.619 1.024-2.560 0.039

Abbreviations: see Table 1.